FullIntel
Media Intelligence for the Biotech Sector
In the rapidly evolving biotechnology industry, narratives shift quickly. Fullintel delivers real-time, analyst-curated intelligence to help you track clinical developments, regulatory news, scientific conversations, and competitive signals without the noise.
Fullintel
Biotech Media Intelligence Capabilities
Our Customers
Working with some of the world's most trusted brands
Tailored Solutions
Why Biotech Leaders Trust Fullintel
Our team carefully monitors complex biotech narratives, ensuring that scientific terms, trial designs, and regulatory language are accurately interpreted. Analysts verify all mentions to deliver intelligence you can rely on during sensitive communications moments.
Your data and reporting remain secure within an encrypted environment supported by strict access controls. Our infrastructure enhances the reliability and confidentiality required by biotech organizations that handle sensitive information.
We support global operations with multilingual monitoring and regionally tailored reporting. Whether your coverage appears in North America, Europe, Asia, or emerging biotech hubs, Fullintel provides localized context and insights.
Cost-Effective , Customizable, 24/7 Support
Secure and Flexible Reporting Options
Crisis Support Briefings: Get rapid, high-frequency updates during safety issues, regulatory escalations, or unexpected media attention.
Intelligence Reports: Receive ongoing curated reports covering clinical, regulatory, scientific, and competitive developments.
Special Topic Briefings: Develop targeted briefings on specific areas, including therapeutic categories, research pipelines, regulatory pathways, or market shifts.
Secure Delivery: Reports are delivered securely through email or your internal systems, supporting your organization’s compliance and confidentiality requirements.
Who We Work With
Fullintel partners with a wide range of biotechnology and life sciences organizations, including:
- Drug development companies are monitoring trial progress and safety messaging
- Research-driven biotechnology firms tracking scientific and regulatory narratives
- Emerging biotech companies preparing for commercialization
- Gene therapy, cell therapy, and precision medicine innovators
- Global pharmaceutical companies with biotech pipelines
- Organizations responding to safety concerns and regulatory scrutiny
- Medical research institutions and scientific associations
Experience
What Our Clients Are Saying:
Trusted Insights, Proven Results
The best way to showcase our commitment is through the experiences and stories of those who have partnered with us.
"Saving close to $30,000 annually which is incredible considering the work quality and efficiency gains."
Lindsay Bohlander
Sr. PR Director, Shionogi Pharmaceuticals
"We came to Fullintel with the particular need to capture media coverage and analyze results in order to affect our campaign activities. Fullintel has been a fantastic partner and we are thrilled to continue our collaboration with the Fullintel team."
Executive Director of Global PR
Major Film Studio
"Understanding the impact and quality of our media coverage is crucial at HelloFresh as we continue to ensure our audiences read, hear and watch the best news and stories."
Max Backhaus
CMO, Hello Fresh
Get Started
Partner With Us for Reliable Biotech Media Intelligence
Biotech communication moves quickly, and every detail matters. Partner with Fullintel for secure, accurate, analyst-curated media intelligence that helps your team anticipate issues, understand scientific narratives, and stay prepared throughout each stage of development. Let’s work together to support your mission of bringing innovation to patients.
Try Fullintel Today
Don’t just monitor the news;
deliver smarter media intelligence with Fullintel.
Explore how our media intelligence platform, backed by human-trained AI and supported by expert media analysts, can save you time and money.Â